Vitamins b and c strong im injection
- Drugs List
- Therapeutic Indications
- Dosage
- Administration
- Contraindications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
- Monograph
Presentation
Pair of ampoules containing:
No1 (5ml ampoule): thiamine hydrochloride 250mg, riboflavin 4mg and pyridoxine hydrochloride 50mg
No2 (2ml ampoule): ascorbic acid 500mg and nicotinamide 160mg.
Drugs List
Therapeutic Indications
Uses
Alcoholism (adjunctive treatment)
Debility - severe (after major surgery or disease)
Vitamin B deficiency
Vitamin C deficiency
Wernickes encephalopathy
Rapid correction of severe depletion or malabsorption of vitamins B and C (e.g. in alcoholism, after acute infections, post operatively and in psychiatric states)
Dosage
This preparation is also available as an Intravenous Strong Injection. Therefore ensure that the labels of the ampoule are for the desired route before administration.
Adults
The mixed contents of one pair of ampoules (7ml) twice daily for up to 7 days.
The following alternative dosing schedule may be suitable:
Prevention of Wernicke's encephalopathy in alcoholism
One pair once a day for at least 5 days and up to 7 days if required.
Children
Children aged 14 to 18 years: See Dosage; Adult.
Children aged 10 to 14 years: One half to two thirds of the adult dose.
Children aged 6 to 10 years: One third of the adult dose.
Children under 6 years: One quarter of the adult dose.
Administration
For intramuscular administration into the gluteal muscle only.
Inject slowly high into the gluteal muscle, 5cm below the iliac crest.
Contraindications
Hypersensitivity to benzyl alcohol
Neonates
Precautions and Warnings
Children under 3 years
Restricted sodium intake
Breastfeeding
Hepatic impairment
Pregnancy
Renal impairment
Contains more than 1 mmol (23 mg) sodium per dose
Contains benzyl alcohol
Do not use if any signs of precipitate or particulate matter apparent
Resuscitation facilities must be immediately available
Use only when parenteral treatment is essential
For intramuscular administration only. Care should be taken to ensure that the route of administration is the desired before administer the product to the patient.
Pregnancy and Lactation
Pregnancy
Use vitamins B and C strong intramuscular injection with caution during pregnancy.
The manufacturer advises caution if vitamins B and C strong intramuscular injection is used during pregnancy. At the time of writing there is limited published information regarding the use of vitamins B and C strong intramuscular injection during pregnancy. Potential risks are unknown.
Lactation
Use vitamins B and C strong intramuscular injection with caution during breastfeeding.
The manufacturer advises caution if vitamins B and C strong intramuscular injection is used when breastfeeding. The presence of vitamins B and C strong intramuscular injection in human breast milk and the effects of exposed infants are unknown.
Side Effects
Anaphylaxis
Hypersensitivity reactions
Hypotension
Local pain (injection site)
Paraesthesia
Overdosage
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Further Information
Last Full Review Date: January 2020
Reference Sources
Summary of Product Characteristics: Pabrinex Intramuscular High Potency Injection. Archimedes Pharma Ltd. Revised July 2018.
NICE Evidence Services Available at: www.nice.org.uk Last accessed: 16 January 2020
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.